Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes
Three years of tirzepatide also reduced risk for progression to type 2 diabetes compared with placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.